A Phase Ib Dose-finding Study of Panobinostat and Ruxolitinib in Myelofibrosis
| Main Authors: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-08-01
|
| Series: | HemaSphere |
| Online Access: | http://journals.lww.com/10.1097/HS9.0000000000000757 |
| _version_ | 1797287196162523136 |
|---|---|
| author | Claire Harrison Florian H. Heidel Alessandro M. Vannucchi Jean-Jacques Kiladjian Amjad Hayat Francesco Passamonti Eibhlin Conneally Thomas Kindler Bruno Martino Daniel B. Lipka Tommaso Stefanelli Pantelia Roussou Davide Germano Jacqueline Ewan Vincent Ribrag |
| author_facet | Claire Harrison Florian H. Heidel Alessandro M. Vannucchi Jean-Jacques Kiladjian Amjad Hayat Francesco Passamonti Eibhlin Conneally Thomas Kindler Bruno Martino Daniel B. Lipka Tommaso Stefanelli Pantelia Roussou Davide Germano Jacqueline Ewan Vincent Ribrag |
| author_sort | Claire Harrison |
| collection | DOAJ |
| first_indexed | 2024-03-07T18:29:28Z |
| format | Article |
| id | doaj.art-e4ad9ac6fbc047909aa7e4c5b130001e |
| institution | Directory Open Access Journal |
| issn | 2572-9241 |
| language | English |
| last_indexed | 2024-03-07T18:29:28Z |
| publishDate | 2022-08-01 |
| publisher | Wiley |
| record_format | Article |
| series | HemaSphere |
| spelling | doaj.art-e4ad9ac6fbc047909aa7e4c5b130001e2024-03-02T06:41:34ZengWileyHemaSphere2572-92412022-08-0168e75710.1097/HS9.0000000000000757202208000-00010A Phase Ib Dose-finding Study of Panobinostat and Ruxolitinib in MyelofibrosisClaire Harrison0Florian H. Heidel1Alessandro M. Vannucchi2Jean-Jacques Kiladjian3Amjad Hayat4Francesco Passamonti5Eibhlin Conneally6Thomas Kindler7Bruno Martino8Daniel B. Lipka9Tommaso Stefanelli10Pantelia Roussou11Davide Germano12Jacqueline Ewan13Vincent Ribrag141 Guy’s and St. Thomas’ NHS Foundation Trust, Guy’s Hospital, London, United Kingdom2 Internal Medicine C, University Medicine Greifswald, Germany3 CRIMM-Centro Ricerca e Innovazione delle Malattie Mieloproliferative, University of Florence, Azienda Ospedaliera–Universitaria Careggi, Florence, Italy4 Hôpital Saint-Louis, Centre d’Investigations Cliniques, INSERM, Université de Paris, AP-HP, Paris, France5 Department of Haematology, University Hospital Galway, Galway, Republic of Ireland6 Division of Hematology, Department of Medicine and Surgery, University of Insubria, Varese, Italy7 Department of Haematology, St James Hospital, Dublin, Ireland8 Department of Hematology, Medical Oncology and Pneumology, University Medical Center of the Johannes Gutenberg University Mainz, Germany9 Az.Osp. Bianchi-Melacrino’-Morelli, Reggio Calabria, Italy10 Section Translational Cancer Epigenomics, Division of Translational Medical Oncology, German Cancer Research Center (DKFZ) & National Center for Tumor Diseases (NCT) Heidelberg, Germany11 Novartis Pharma AG, Basel, Switzerland11 Novartis Pharma AG, Basel, Switzerland11 Novartis Pharma AG, Basel, Switzerland12 Novartis Pharmaceuticals UK Limited, London, United Kingdom13 Institut Gustave Roussy, Villejuif, Francehttp://journals.lww.com/10.1097/HS9.0000000000000757 |
| spellingShingle | Claire Harrison Florian H. Heidel Alessandro M. Vannucchi Jean-Jacques Kiladjian Amjad Hayat Francesco Passamonti Eibhlin Conneally Thomas Kindler Bruno Martino Daniel B. Lipka Tommaso Stefanelli Pantelia Roussou Davide Germano Jacqueline Ewan Vincent Ribrag A Phase Ib Dose-finding Study of Panobinostat and Ruxolitinib in Myelofibrosis HemaSphere |
| title | A Phase Ib Dose-finding Study of Panobinostat and Ruxolitinib in Myelofibrosis |
| title_full | A Phase Ib Dose-finding Study of Panobinostat and Ruxolitinib in Myelofibrosis |
| title_fullStr | A Phase Ib Dose-finding Study of Panobinostat and Ruxolitinib in Myelofibrosis |
| title_full_unstemmed | A Phase Ib Dose-finding Study of Panobinostat and Ruxolitinib in Myelofibrosis |
| title_short | A Phase Ib Dose-finding Study of Panobinostat and Ruxolitinib in Myelofibrosis |
| title_sort | phase ib dose finding study of panobinostat and ruxolitinib in myelofibrosis |
| url | http://journals.lww.com/10.1097/HS9.0000000000000757 |
| work_keys_str_mv | AT claireharrison aphaseibdosefindingstudyofpanobinostatandruxolitinibinmyelofibrosis AT florianhheidel aphaseibdosefindingstudyofpanobinostatandruxolitinibinmyelofibrosis AT alessandromvannucchi aphaseibdosefindingstudyofpanobinostatandruxolitinibinmyelofibrosis AT jeanjacqueskiladjian aphaseibdosefindingstudyofpanobinostatandruxolitinibinmyelofibrosis AT amjadhayat aphaseibdosefindingstudyofpanobinostatandruxolitinibinmyelofibrosis AT francescopassamonti aphaseibdosefindingstudyofpanobinostatandruxolitinibinmyelofibrosis AT eibhlinconneally aphaseibdosefindingstudyofpanobinostatandruxolitinibinmyelofibrosis AT thomaskindler aphaseibdosefindingstudyofpanobinostatandruxolitinibinmyelofibrosis AT brunomartino aphaseibdosefindingstudyofpanobinostatandruxolitinibinmyelofibrosis AT danielblipka aphaseibdosefindingstudyofpanobinostatandruxolitinibinmyelofibrosis AT tommasostefanelli aphaseibdosefindingstudyofpanobinostatandruxolitinibinmyelofibrosis AT panteliaroussou aphaseibdosefindingstudyofpanobinostatandruxolitinibinmyelofibrosis AT davidegermano aphaseibdosefindingstudyofpanobinostatandruxolitinibinmyelofibrosis AT jacquelineewan aphaseibdosefindingstudyofpanobinostatandruxolitinibinmyelofibrosis AT vincentribrag aphaseibdosefindingstudyofpanobinostatandruxolitinibinmyelofibrosis AT claireharrison phaseibdosefindingstudyofpanobinostatandruxolitinibinmyelofibrosis AT florianhheidel phaseibdosefindingstudyofpanobinostatandruxolitinibinmyelofibrosis AT alessandromvannucchi phaseibdosefindingstudyofpanobinostatandruxolitinibinmyelofibrosis AT jeanjacqueskiladjian phaseibdosefindingstudyofpanobinostatandruxolitinibinmyelofibrosis AT amjadhayat phaseibdosefindingstudyofpanobinostatandruxolitinibinmyelofibrosis AT francescopassamonti phaseibdosefindingstudyofpanobinostatandruxolitinibinmyelofibrosis AT eibhlinconneally phaseibdosefindingstudyofpanobinostatandruxolitinibinmyelofibrosis AT thomaskindler phaseibdosefindingstudyofpanobinostatandruxolitinibinmyelofibrosis AT brunomartino phaseibdosefindingstudyofpanobinostatandruxolitinibinmyelofibrosis AT danielblipka phaseibdosefindingstudyofpanobinostatandruxolitinibinmyelofibrosis AT tommasostefanelli phaseibdosefindingstudyofpanobinostatandruxolitinibinmyelofibrosis AT panteliaroussou phaseibdosefindingstudyofpanobinostatandruxolitinibinmyelofibrosis AT davidegermano phaseibdosefindingstudyofpanobinostatandruxolitinibinmyelofibrosis AT jacquelineewan phaseibdosefindingstudyofpanobinostatandruxolitinibinmyelofibrosis AT vincentribrag phaseibdosefindingstudyofpanobinostatandruxolitinibinmyelofibrosis |